Explore best practices for storing medical devices and pharmaceutical products to maintain their integrity and safety. Ensure efficacy with expert guidelines from pharma consulting firms.
For the safety of patients and quality of products, the pharmaceutical industry is regulated under a wide spectrum of rules and regulations. 21 CFR Section 820.150 highlights the importance of proper storage practices, primarily concerning the following: control of storage areas and stock rooms; avoiding mix-ups and contamination; handling obsolete products; retaining products susceptible to time-related deterioration; and regular reception and dispatch with systematic procedures.
Control of Storage Areas and Stock Rooms
The pharmaceutical industry encompasses a wide range of medical apparatus and drugs from the simplest drugs to highly sophisticated pieces of medical equipment. Storage rooms and stockrooms should be managed properly to avoid mix-up, damage, deterioration, and contamination of products, or other adverse effects. This directive stipulates that medical apparatus left pending for use or in preparation for distribution is safe, and thus may be distributed without the risk of compromising the integrity of the product. Storage areas with controlled access are necessary to avoid unauthorized handling or tampering.
Prevention of Mix-ups and Contamination
Mix-ups of medical devices can prove to be disastrous both for patients, healthcare service providers, and manufacturers. Manufacturers can significantly lessen the risks associated with incorrect distribution, administration, or usage of products by establishing and maintaining stringent storage procedures. Pharma industry deals with sensitive drugs and devices and are more liable to contamination. Stringent controls over storage prevent contamination of the products so that they remain safe for use by the patients throughout their shelf life. Maintaining the quality of the products through proper storage systems will protect the reputation of the drug manufacturers.
Handling Obsolete, Rejected, or Deteriorated Products
The quality of the products is of utmost concern in pharmaceuticals. Obsolete, rejected, or deteriorated products would be hazardous and cause non-compliance with regulations. The proper storage protocol can help manufacturers identify these obsolete products and segregate them from current product inventories, thereby making them unavailable for misuse or distribution to potential consumers; this can lead to proper disposal or corrective measures. Proper management of the inventory and reviewing it periodically against the products kept in the store will prevent the use of expired products and have a streamlined supply chain of the manufacturer.
Time-Dependent Product Degradation
Many drug products and medical devices degrade over time when they are kept improperly. Temperature changes, exposure to light, and high humidity have a direct impact on the the stability of pharmaceutical products. Due to this degradation process, products must be stored in a system that allows appropriate stock rotation. This ensures that the older products are utilized first and lastly the new ones, thus minimizing wastage, and ensuring that the patient receives the high quality of products. Therefore, repeated checks and implementation of stability studies ensure that the products remain potent and effective throughout their shelf life.
Systematic Receipt and Dispatch Procedure
The regulation demands that procedures for authorization receipt from and dispatch to storage areas and stockrooms be provided. Good and well-defined procedures regarding receipt and dispatch enhance traceability and accountability while reducing the risks of misplaced and mismanaged medical devices at every step involved with receiving and dispatching them. Proper documentation for the receipt and dispatch activities proves crucial in establishing authenticity and allowing smoother facilitation in case of recalls and compliance with the regulatory assessment.
Compliance and Regulatory Requirement
The storage regulations provide that pharmaceutical manufacturers face severe penalties when they fail to obey the provisions of those regulations. That may include issuance of warning letters, fines, product recalls, suspension of production and distribution or loss of goodwill based on inadequate quality products, which leads to loss of trust from healthcare providers and patients as well as other stakeholders. Therefore, to avert such incidences, pharmaceutical firms must strictly abide by the provisions in Subpart L.
Conclusion
In the pharmaceutical industry, adherence to Section 820.150 of Subpart L – Handling, Storage, Distribution, and Installation within Part 820 – Quality System Regulation should be urged. Appropriate storage practices are the foundation for integrity, safety, and efficacy of medical devices and products. Manufacturers can effectively provide patients with the best possible care and safety through effective storage areas and stock rooms, prevent mix-ups and contamination, manage obsolete or rejected products, track time-dependent deterioration, methodical receipt and dispatch procedures, and fulfill all regulatory requirements.
Visit our website to learn more about how we can help your organization.
